Articles
Volume 8 Supplement 2
Breast cancer research: the past and the future
Meeting abstracts
Breast cancer research: the past and the future
London, UK
1 November 2006
|
Breast cancer susceptibility after BRCA1/2: finding the genes and potential practical applications BAJ Ponder, AM Dunning, DF Easton, PDP Pharoah Breast Cancer Research 2006, 8(Suppl 2):S1 (1 November 2006) |
|
Translating breast cancer research into clinical practice — new approaches and better outcomes SRD Johnston Breast Cancer Research 2006, 8(Suppl 2):S2 (1 November 2006) |
|
Evolution of aromatase inhibitors as an endocrine treatment for breast cancer WR Miller Breast Cancer Research 2006, 8(Suppl 2):S3 (1 November 2006) |
|
BRCA1 transcriptionally regulates genes associated with the basal breast cancer phenotype JE Quinn, CR James, JJ Gorskii, PB Mullan, DP Harkin Breast Cancer Research 2006, 8(Suppl 2):S4 (1 November 2006) |
|
Regulation of recombinational repair by the familial breast cancer susceptibility protein BRCA2 SC West, F Esashi Breast Cancer Research 2006, 8(Suppl 2):S5 (1 November 2006) |
|
Chromosome translocations may play a significant role in breast cancer KL Howarth, KA Blood, JC Pole, SL Cooke, Y-L Chua, JC Beavis, B-L Ng, PAW Edwards Breast Cancer Research 2006, 8(Suppl 2):S6 (1 November 2006) |
|
Regulation of human breast stem cells RB Clarke Breast Cancer Research 2006, 8(Suppl 2):S7 (1 November 2006) |
|
Aberrant activation of Notch signalling in human breast cancer S Stylianou, GM Collu, RB Clarke, K Brennan Breast Cancer Research 2006, 8(Suppl 2):S8 (1 November 2006) |
|
Novel roles for integrins in tumour angiogenesis M Germain, R Silva, L Reynolds, S Robinson, M DiPersio, J Kreidberg, E Georges-Labouesse, K Hodivala-Dilke Breast Cancer Research 2006, 8(Suppl 2):S9 (1 November 2006) |
|
Genome-wide RNAi to identify genes that confer synthetic lethality with BRCA1 MIR Petalcorin, JS Martin, SJ Boulton Breast Cancer Research 2006, 8(Suppl 2):S10 (1 November 2006) |
|
Microarray studies reveal novel genes associated with endocrine resistance in breast cancer RS Burmi, RA McClelland, D Barrow, IO Ellis, JFR Robertson, RI Nicholson, JMW Gee Breast Cancer Research 2006, 8(Suppl 2):S11 (1 November 2006) |
|
Benefits of combined treatments using antiresorptive agents and cytotoxic drugs I Holen, H Neville-Webbe, RE Coleman Breast Cancer Research 2006, 8(Suppl 2):S12 (1 November 2006) |
|
L Bergman, J Blaydes Breast Cancer Research 2006, 8(Suppl 2):P1 (1 November 2006) |
|
Phenotypic characterization of mouse mammary epithelial stem and progenitor cells J Stingl, CJ Eaves, CJ Watson Breast Cancer Research 2006, 8(Suppl 2):P2 (1 November 2006) |
|
Characterisation of the tumour suppressor gene EM Valleley, SF Cordery, M Shires, V Speirs, DT Bonthron Breast Cancer Research 2006, 8(Suppl 2):P3 (1 November 2006) |
|
Role of BRCT motif containing proteins in Chk1 activation RG Beniston, CGW Smythe Breast Cancer Research 2006, 8(Suppl 2):P4 (1 November 2006) |
|
The YL Chua, PAW Edwards Breast Cancer Research 2006, 8(Suppl 2):P5 (1 November 2006) |
|
hCLK2 couples FANCD2 to stalled replication forks and functions in the mammalian S-phase checkpoint SJ Collis, LJ Barber, JS Martin, JD Ward, SJ Boulton Breast Cancer Research 2006, 8(Suppl 2):P6 (1 November 2006) |
|
Poly(ADPribosyl)ation of CTCF: role in breast tumourigenesis F Docquier, D Farrar, I Chernukhin, E Klenova Breast Cancer Research 2006, 8(Suppl 2):P7 (1 November 2006) |
|
Investigating the role of Wnt signalling in lobuloalveolar development of the mammary gland RJ Evans, C Dale Breast Cancer Research 2006, 8(Suppl 2):P8 (1 November 2006) |

